Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases

Airway stents improve respiratory conditions and Eastern Cooperative Oncology Group Performance Status scores in cases of airway stenosis, as observed in patients with stage III non-small cell lung cancer (NSCLC) who experience prolonged survival after undergoing chemoradiotherapy followed by durvalumab treatment. Herein, we report three cases of severe airway stenosis due to stage III NSCLC in patients who underwent airway stenting and subsequent stent removal after chemoradiotherapy and durvalumab administration. The number of stents removed will likely increase in the future due to the high response rates to molecular drugs and immune checkpoint inhibitors.

Authors

Institutions

Publication Details

Journal
Respiratory Medicine Case Reports
Published
2025-01-01
DOI
https://doi.org/10.1016/j.rmcr.2025.102217
Primary Topic
Tracheal and airway disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases

Tomoyoshi Inoue, Hiroyasu Shoda, Miho Fujiwara, Yuki Takigawa et al.
3 links
Respiratory Medicine Case Reports
Tracheal and airway disorders
article

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases

Tomoyoshi Inoue, Hiroyasu Shoda, Miho Fujiwara, Yuki Takigawa, Shoichiro Matsumoto, Keiichi Fujiwara, Kenichiro Kudo, Daisuke Minami, Ken Sato, Akiko Sato, Hiromi Watanabe, Nobuhisa Ishikawa, Takuo Shibayama, Takeru Ichikawa, Suzuka Matsuoka
article en

Abstract

Airway stents improve respiratory conditions and Eastern Cooperative Oncology Group Performance Status scores in cases of airway stenosis, as observed in patients with stage III non-small cell lung cancer (NSCLC) who experience prolonged survival after undergoing chemoradiotherapy followed by durvalumab treatment. Herein, we report three cases of severe airway stenosis due to stage III NSCLC in patients who underwent airway stenting and subsequent stent removal after chemoradiotherapy and durvalumab administration. The number of stents removed will likely increase in the future due to the high response rates to molecular drugs and immune checkpoint inhibitors.

Respiratory Medicine Case ReportsVol. 55
Kawasaki Medical School (JP), Hiroshima City Asa Citizens Hospital (JP), Hiroshima Prefectural Hospital (JP), Okayama Medical Center (JP)
Good health and well-being
Openalex Percentile: Top 88%
Tracheal and airway disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases — Tomoyoshi Inoue, Hiroyasu Shoda, et al. · Respiratory Medicine Case Reports (2025) | TGRS Research Map | TGRS